First Time Loading...
S

Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233

Watchlist Manager
Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233
Watchlist
Price: 16.21 CNY 3.78% Market Closed
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shandong Jincheng Pharmaceutical Group Co Ltd

Wall Street analysts forecast Shandong Jincheng Pharmaceutical Group Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Jincheng Pharmaceutical Group Co Ltd is 5.54 CNY .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
5.54 CNY
66% Downside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
5.54 CNY
66% Downside
Highest
Price Target
Not Available
Shandong Jincheng Pharmaceutical Group Co Ltd Competitors:
Price Targets
000538
Yunnan Baiyao Group Co Ltd
18% Upside
SNDL
Sundial Growers Inc
90% Upside
ELVN
Enliven Therapeutics Inc
109% Upside
1760
Panion & BF Biotech Inc
13% Upside
000538
Yunnan Baiyao Group Co Ltd
18% Upside
SNDL
Sundial Growers Inc
90% Upside
ELVN
Enliven Therapeutics Inc
109% Upside
1760
Panion & BF Biotech Inc
13% Upside
M
MEGA
Mega Lifesciences PCL
21% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
3% Downside
A
002821
Asymchem Laboratories Tianjin Co Ltd
88% Upside
H
600566
Hubei Jumpcan Pharmaceutical Co Ltd
8% Upside

Revenue
Forecast

Revenue Estimate
Shandong Jincheng Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shandong Jincheng Pharmaceutical Group Co Ltd's revenue is 15%. The projected CAGR for the next 1 year is 46%.

15%
Past Growth
46%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shandong Jincheng Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shandong Jincheng Pharmaceutical Group Co Ltd's operating income is 4%. The projected CAGR for the next 2 years is -8%.

4%
Past Growth
-8%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shandong Jincheng Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shandong Jincheng Pharmaceutical Group Co Ltd's net income is 0%. The projected CAGR for the next 1 year is 305%.

0%
Past Growth
305%
Estimated Growth
Estimates Accuracy
-32%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Jincheng Pharmaceutical Group Co Ltd's stock price target?
Price Target
5.54 CNY

According to Wall Street analysts, the average 1-year price target for Shandong Jincheng Pharmaceutical Group Co Ltd is 5.54 CNY .

What is Shandong Jincheng Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
46%

For the last 8 years the compound annual growth rate for Shandong Jincheng Pharmaceutical Group Co Ltd's revenue is 15%. The projected CAGR for the next 1 year is 46%.

What is Shandong Jincheng Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
-8%

For the last 8 years the compound annual growth rate for Shandong Jincheng Pharmaceutical Group Co Ltd's operating income is 4%. The projected CAGR for the next 2 years is -8%.

What is Shandong Jincheng Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
305%

For the last 8 years the compound annual growth rate for Shandong Jincheng Pharmaceutical Group Co Ltd's net income is 0%. The projected CAGR for the next 1 year is 305%.

ALPHA SPREAD
Join more than 131,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.